HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.
企業コードBEAT
会社名Heartbeam Inc
上場日Oct 14, 2021
最高経営責任者「CEO」Mr. Robert P. (Rob) Eno
従業員数21
証券種類Ordinary Share
決算期末Oct 14
本社所在地2118 Walsh Ave., Suite 210
都市SANTA CLARA
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号95050
電話番号14088994443
ウェブサイトhttps://www.heartbeam.com/
企業コードBEAT
上場日Oct 14, 2021
最高経営責任者「CEO」Mr. Robert P. (Rob) Eno
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし